RAD-x adds Radiologisches Zentrum Lahnstein (RZL) to its group - Gilde Healthcare

RAD-x adds Radiologisches Zentrum Lahnstein (RZL) to its group

19. Januar 2021

Utrecht (the Netherlands) – RAD-x is welcoming Radiologisches Zentrum Lahnstein (“RZL”) in its group.

Radiologisches Zentrum Lahnstein is a provider of diagnostic imaging services in the region Koblenz, Germany. Its three radiologists and almost 30 staff serve the community in and around Lahnstein and provide imaging services to several local hospitals.

RAD-x is pleased to see its Partnership model confirmed by the integration of RZL and expects to further accelerate the growth of its platform structure in 2021.

 

About Gilde Healthcare

Gilde Healthcare is a specialized healthcare investor managing over $1.5 billion across two fund strategies: venture & growth capital and private equity. Gilde Healthcare’s venture & growth capital fund invests in fast growing companies active in digital health, MedTech and therapeutics. The venture & growth companies are based in Europe and North America. For more information, visit the company’s website at www.gildehealthcare.com.

Mehr neuigkeiten

Okami Medical Announces $45 Million Financing and New CEO Appointment to Drive Next Phase of Growth

Okami Medical, a medical technology company pioneering novel vascular embolization solutions, today announced the successful close of an oversubscribed $45M financing led by new investor Gilde Healthcare with participation from existing investors including Vensana Capital and...
20. November 2025

Gilde Healthcare erwirbt MEG, eine Gruppe spezialisierter Anbieter medizinischer Hilfsmittel, von Harald Quandt Industriebeteiligungen („HQIB“)

Der Private Equity Fonds von Gilde Healthcare gab heute den Erwerb der MEG Medical Equipment GmbH („MEG“) von HQIB bekannt. MEG ist ein Anbieter hochwertiger medizinischer Hilfsmittel zur Behandlung und Vorbeugung von Dekubitus und andere...
14. November 2025

Boston Scientific to Acquire Nalu Medical

We are pleased to announce the strategic exit of our portfolio company Nalu Medical. Boston Scientific, a global leader in medical technology, has agreed to acquire Gilde Healthcare portfolio company Nalu Medical at a $600m valuation....
17. Oktober 2025